Source briefing
Human medicines European public assessment report (EPAR): Blenrep, belantamab mafodotin, Date of authorisation: 23/07/2025, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Blenrep, belantamab mafodotin, Date of authorisation: 23/07/2025, Revision: 3, Status: Authorised
Read →
Source briefing
List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment
List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment
Read →Source briefing
Estimates of global burden of snakebite: A literature review and geostatistical modelling study
by Dileepa Senajith Ediriweera, Anuradhani Kasturiratne, Arunasalam Pathmeswaran, Ymkje Stienstra, Gerardo Martín, Takuya Iwamura, Kris A. Murray, Hithanadura Janaka de Silva, Peter John Diggle, David Griffith Lalloo Background Snake envenoming (SE) remains an important public health problem, disproportionately…
Read →
Source briefing
Sex differences in trajectories to cardio-renal and mental health outcomes following the onset of type 2 diabetes: An observational cohort study using multi-state analysis in the UK Clinical Practice Research Datalink
by Fabiola Eto, Miriam Samuel, Daniel Stow, Rafael Henkin, Alisha Angdembe, Michael R. Barnes, Sarah Finer, Rohini Mathur Background Type 2 diabetes (T2D) presents a significant global health challenge, and its prevalence is expected to rise. T2D is…
Read →Source briefing
Frequency and prognostic outcomes of emergency diagnosis in 13 non-neoplastic conditions in England: A population-based cohort study using linked electronic health records of 1.7 million patients
by Emma Whitfield, Becky White, Matthew E. Barclay, Meena Rafiq, Nadine Zakkak, Marta Berglund, Hardeep Singh, Sean McPhail, Spiros Denaxas, Georgios Lyratzopoulos Background In patients with cancer, diagnosis through or soon after the use of emergency hospital care…
Read →Source briefing
Human medicines European public assessment report (EPAR): Akynzeo, netupitant,palonosetron, Date of authorisation: 27/05/2015, Revision: 23, Status: Authorised
Human medicines European public assessment report (EPAR): Akynzeo, netupitant,palonosetron, Date of authorisation: 27/05/2015, Revision: 23, Status: Authorised
Read →Source briefing
Human medicines European public assessment report (EPAR): Ablymico, liraglutide, Date of authorisation: 15/07/2026, Status: Authorised
Human medicines European public assessment report (EPAR): Ablymico, liraglutide, Date of authorisation: 15/07/2026, Status: Authorised
Read →Source briefing
Human medicines European public assessment report (EPAR): Hopledo, levodopa,carbidopa, Date of authorisation: 20/08/2026, Status: Authorised
Human medicines European public assessment report (EPAR): Hopledo, levodopa,carbidopa, Date of authorisation: 20/08/2026, Status: Authorised
Read →Source briefing
Kazakhstan’s Election Brings a New Parliament — and More Pressure on Journalists
President Kassym-Jomart Tokayev’s allies dominated the vote as independent observers raised concerns over a campaign marked by restrictions on critical voices.
Read →Source briefing
Trends of stillbirth, early neonatal and perinatal mortality rates and sociodemographic differentials of perinatal mortality rates in 17 low- and middle-income countries: A modeling study
by Mohamed M. Ali, Luca Cegolon, Saverio Bellizzi Background Stillbirths and early neonatal deaths account for a substantial proportion of global child mortality. Reliable measurement of these outcomes remains challenging in settings where civil registration systems are incomplete…
Read →